These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 80265)

  • 21. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
    Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
    Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and copper(II)-binding properties of the N-terminal peptide of human alpha-fetoprotein.
    Lau SJ; Laussac JP; Sarkar B
    Biochem J; 1989 Feb; 257(3):745-50. PubMed ID: 2467660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the Zn(II) site in the copper-responsive yeast transcription factor, AMT1: a conserved Zn module.
    Farrell RA; Thorvaldsen JL; Winge DR
    Biochemistry; 1996 Feb; 35(5):1571-80. PubMed ID: 8634288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.
    Miura T; Hori-i A; Mototani H; Takeuchi H
    Biochemistry; 1999 Aug; 38(35):11560-9. PubMed ID: 10471308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-fetoprotein and its relevance to human disease.
    Wepsic HT; Kirkpatrick A
    Gastroenterology; 1979 Oct; 77(4 Pt 1):787-96. PubMed ID: 89060
    [No Abstract]   [Full Text] [Related]  

  • 26. Copper(II) interaction with prion peptide fragments encompassing histidine residues within and outside the octarepeat domain: speciation, stability constants and binding details.
    Osz K; Nagy Z; Pappalardo G; Di Natale G; Sanna D; Micera G; Rizzarelli E; Sóvágó I
    Chemistry; 2007; 13(25):7129-43. PubMed ID: 17566127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of lectins with their ligand carbohydrate of alpha-fetoprotein: analysis by mixed-lectin affinity electrophoresis.
    Taketa K; Liu M; Taga H
    Electrophoresis; 1996 Mar; 17(3):483-8. PubMed ID: 8740163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on human alpha-fetoprotein. Isolation and characterization of monomeric and polymeric forms and amino-terminal sequence analysis.
    Yachnin S; Hsu R; Heinrikson RL; Miller JB
    Biochim Biophys Acta; 1977 Aug; 493(2):418-28. PubMed ID: 70228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract]   [Full Text] [Related]  

  • 30. The fatty acid binding site of human alpha-fetoprotein.
    Nishihira J; Koyama Y; Sakai M; Nishi S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1049-57. PubMed ID: 7504462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fatty acid levels of rat alpha-fetoprotein derived from fetuses, pregnancy and hepatoma sera.
    Nagai M; Becker JL; Deutsch HF
    Oncodev Biol Med; 1982; 3(5-6):343-50. PubMed ID: 6183647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum concentrations of alpha-1-fetoprotein suggestive of, or pathognomonic for hepatoma (author's transl)].
    Polterauer P; Horak W; Legenstein E; Müller M
    Wien Klin Wochenschr; 1979 Mar; 91(6):201-4. PubMed ID: 85372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake.
    Miura T; Sasaki S; Toyama A; Takeuchi H
    Biochemistry; 2005 Jun; 44(24):8712-20. PubMed ID: 15952778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium-binding properties of fetuin in fetal bovine serum.
    Suzuki M; Shimokawa H; Takagi Y; Sasaki S
    J Exp Zool; 1994 Dec; 270(6):501-7. PubMed ID: 7528258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-linked immunosorbent assay for alpha-fetoprotein in human serum.
    Chui SH; Yow CM; Lam CW; Wan KC; Lewis WH
    Med Lab Sci; 1989 Oct; 46(4):305-8. PubMed ID: 2482399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum copper, ceruloplasmin, protein thiols and thiobarbituric acid reactive substance status in liver cancer associated with elevated levels of alpha-fetoprotein.
    Nayak SB; Yashwanth S; Pinto SM; Bhat VR; Mayya SS
    Indian J Physiol Pharmacol; 2005; 49(3):341-4. PubMed ID: 16440854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodynamic and spectroscopic study of Cu(II) and Ni(II) binding to bovine serum albumin.
    Zhang Y; Wilcox DE
    J Biol Inorg Chem; 2002 Mar; 7(3):327-37. PubMed ID: 11935357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of combined assays of serum ferritin, alpha-1-antitrypsin and alpha-fetoprotein in liver cancer.
    Tang DJ; Lang YM; Feng YZ
    Chin Med J (Engl); 1992 Nov; 105(11):900-4. PubMed ID: 1284788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.